Comparing the Brief Assessment of Cognitive Health and Montreal Cognitive Assessment: Test‐retest reliability and sensitivity to cognitive change in older adults

Abstract Background Test‐retest reliability for existing cognitive screening tests is typically poor and most have ceiling effects and restricted score ranges that mask the presence of subtle decline. The Brief Assessment of Cognitive Health (BACH) is a computerized cognitive screening tool that patients complete independently. It includes a complex memory test without ceiling effects and brief mood and history questions. The BACH generates a probability score for cognitive impairment that is highly accurate at predicting impairment on neuropsychological testing. The goal of this study was to determine if the psychometric characteristics of BACH (i.e., test‐retest reliability and sensitivity to cognitive change) are superior compared to a commonly used screening test, the Montreal Cognitive Assessment (MoCA). Method Ninety‐seven participants completed the BACH and MoCA at two timepoints. A mixed effects model was fit to derive between‐ and within‐subjects variability to calculate the intraclass correlation coefficient (ICC) to assess test‐retest reliability of the screening tools. A subset of 52 participants completed the same neuropsychological battery at both timepoints and individual composite cognitive change scores were calculated. Pearson correlations were used to determine the strength of relationships between the composite cognitive change score and change scores on the MoCA and BACH. Result On average, the ICC sample was 68 years‐old with 15 years education, and 56% were female. The median time between test sessions was 384 days (range 246‐1211). ICC for the BACH probability of impairment score was 0.59 (moderate reliability) whereas the ICC for the MoCA was 0.48 (poor reliability). For the cognitive testing sample (average age = 72 years, 16 years ed, 54% female), median time between test sessions was 336 days (range 263‐426). Composite cognitive change score was moderately related to BACH probability change (r = ‐0.49; CI = [‐0.68, ‐0.26]) and strongly related to BACH memory score change (r = 0.55; CI = [0.32, 0.71]). Composite cognitive change score was weakly associated with MoCA change score (r = 0.12; CI = [‐0.17, 0.38]). Conclusion The BACH demonstrated moderate to strong test‐retest reliability and sensitivity to cognitive change, while observed MoCA psychometrics were below the cutoffs recommended for clinical practice. The BACH is a more accurate tool for cognitive surveillance in older adults.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2024-12-01
DOI
https://doi.org/10.1002/alz.094295
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comparing the Brief Assessment of Cognitive Health and Montreal Cognitive Assessment: Test‐retest reliability and sensitivity to cognitive change in older adults

Michael B. Rothberg, Olivia Hogue, Alex Milinovich, Darlene Floden et al.
Alzheimer s & Dementia
Dementia and Cognitive Impairment Research
article

Comparing the Brief Assessment of Cognitive Health and Montreal Cognitive Assessment: Test‐retest reliability and sensitivity to cognitive change in older adults

Michael B. Rothberg, Olivia Hogue, Alex Milinovich, Darlene Floden, Robert J. Fox, Saket Saxena, Kamini Krishnan, Elizabeth R. Pfoh, Robyn M. Busch, Michael W. Kattan, Claire Sonneborn, Anita D. Misra‐Hebert, Kelsey Curran
article en

Abstract

Abstract Background Test‐retest reliability for existing cognitive screening tests is typically poor and most have ceiling effects and restricted score ranges that mask the presence of subtle decline. The Brief Assessment of Cognitive Health (BACH) is a computerized cognitive screening tool that patients complete independently. It includes a complex memory test without ceiling effects and brief mood and history questions. The BACH generates a probability score for cognitive impairment that is highly accurate at predicting impairment on neuropsychological testing. The goal of this study was to determine if the psychometric characteristics of BACH (i.e., test‐retest reliability and sensitivity to cognitive change) are superior compared to a commonly used screening test, the Montreal Cognitive Assessment (MoCA). Method Ninety‐seven participants completed the BACH and MoCA at two timepoints. A mixed effects model was fit to derive between‐ and within‐subjects variability to calculate the intraclass correlation coefficient (ICC) to assess test‐retest reliability of the screening tools. A subset of 52 participants completed the same neuropsychological battery at both timepoints and individual composite cognitive change scores were calculated. Pearson correlations were used to determine the strength of relationships between the composite cognitive change score and change scores on the MoCA and BACH. Result On average, the ICC sample was 68 years‐old with 15 years education, and 56% were female. The median time between test sessions was 384 days (range 246‐1211). ICC for the BACH probability of impairment score was 0.59 (moderate reliability) whereas the ICC for the MoCA was 0.48 (poor reliability). For the cognitive testing sample (average age = 72 years, 16 years ed, 54% female), median time between test sessions was 336 days (range 263‐426). Composite cognitive change score was moderately related to BACH probability change (r = ‐0.49; CI = [‐0.68, ‐0.26]) and strongly related to BACH memory score change (r = 0.55; CI = [0.32, 0.71]). Composite cognitive change score was weakly associated with MoCA change score (r = 0.12; CI = [‐0.17, 0.38]). Conclusion The BACH demonstrated moderate to strong test‐retest reliability and sensitivity to cognitive change, while observed MoCA psychometrics were below the cutoffs recommended for clinical practice. The BACH is a more accurate tool for cognitive surveillance in older adults.

Alzheimer s & DementiaVol. 20(S10)
Cleveland Clinic (US)
Openalex Percentile: Top 64%
Dementia and Cognitive Impairment Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.